Penumbra (PEN) EBIT Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -517.00 |
| Dec 31, 2025 | 160.00 |
| Sep 30, 2025 | 174.00 |
| Jun 30, 2025 | -42.00 |
| Mar 31, 2025 | -111.00 |
| Dec 31, 2024 | 181.00 |
| Sep 30, 2024 | 3,879.00 |
| Jun 30, 2024 | -3,138.00 |
| Mar 31, 2024 | -796.00 |
| Dec 31, 2023 | 765.00 |
| Sep 30, 2023 | -218.00 |
| Jun 30, 2023 | 352.00 |
| Mar 31, 2023 | 113.00 |
| Dec 31, 2022 | -36.00 |
| Sep 30, 2022 | 261.00 |
| Jun 30, 2022 | 192.00 |
| Mar 31, 2022 | 1,765.00 |
| Dec 31, 2021 | -2,425.00 |
| Sep 30, 2021 | -98.00 |
| Jun 30, 2021 | -236.00 |
| Mar 31, 2021 | 900.00 |
| Dec 31, 2020 | 1,230.00 |
| Sep 30, 2020 | 345.00 |
| Jun 30, 2020 | -1,724.00 |
| Mar 31, 2020 | -684.00 |
| Dec 31, 2019 | -202.00 |
| Sep 30, 2019 | -24.00 |
| Jun 30, 2019 | 86.00 |
| Mar 31, 2019 | 316.00 |
| Dec 31, 2018 | 2,417.00 |
| Sep 30, 2018 | -2,711.00 |
| Jun 30, 2018 | 453.00 |
| Mar 31, 2018 | -8.00 |
| Dec 31, 2017 | 320.00 |
| Sep 30, 2017 | 246.00 |
| Jun 30, 2017 | 115.00 |
| Mar 31, 2017 | -122.00 |
| Dec 31, 2016 | 45.00 |
| Sep 30, 2016 | -100.00 |
| Jun 30, 2016 | -420.00 |
| Mar 31, 2016 | -18.00 |
| Dec 31, 2015 | -98.00 |
| Sep 30, 2015 | 1,334.00 |
| Jun 30, 2015 | -1,926.00 |
| Mar 31, 2015 | 933.00 |
| Dec 31, 2014 | -5.00 |
| Sep 30, 2014 | -6,480.00 |
| Jun 30, 2014 | -96.00 |